Opus Genetics, Inc. (IRD) — Cash Flow Reinvestment Rate
Latest as of December 2023:
0.00x
Opus Genetics, Inc. (IRD) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $4.55 Million. See Opus Genetics, Inc. balance sheet independence to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$4.55 Million
USD
Capital Expenditures
$0.00
USD
Opus Genetics, Inc. Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Opus Genetics, Inc. across 1 annual periods. Also explore total assets of Opus Genetics, Inc. for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Opus Genetics, Inc. (2022–2022)
Year-by-year capital reinvestment analysis for Opus Genetics, Inc.. For live market cap and broader valuation context, see IRD market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.00x | $0.00 | $14.31 Million | $0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow